426 related articles for article (PubMed ID: 31082188)
1. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery.
Chen W; Glackin CA; Horwitz MA; Zink JI
Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-Responsive Nanomachines and Caps for Drug Delivery.
Kumar N; Chen W; Cheng CA; Deng T; Wang R; Zink JI
Enzymes; 2018; 43():31-65. PubMed ID: 30244808
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery.
Cheng CA; Deng T; Lin FC; Cai Y; Zink JI
Theranostics; 2019; 9(11):3341-3364. PubMed ID: 31244957
[TBL] [Abstract][Full Text] [Related]
4. Functioning of nanovalves on polymer coated mesoporous silica Nanoparticles.
Dong J; Xue M; Zink JI
Nanoscale; 2013 Nov; 5(21):10300-6. PubMed ID: 24056925
[TBL] [Abstract][Full Text] [Related]
5. Externally Controlled Nanomachines on Mesoporous Silica Nanoparticles for Biomedical Applications.
Rühle B; Saint-Cricq P; Zink JI
Chemphyschem; 2016 Jun; 17(12):1769-79. PubMed ID: 26840996
[TBL] [Abstract][Full Text] [Related]
6. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
Chen W; Cheng CA; Zink JI
ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
8. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
9. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
11. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-Powered Gated Mesoporous Silica Nanomotors for On-Command Intracellular Payload Delivery.
Llopis-Lorente A; García-Fernández A; Murillo-Cremaes N; Hortelão AC; Patiño T; Villalonga R; Sancenón F; Martínez-Máñez R; Sánchez S
ACS Nano; 2019 Oct; 13(10):12171-12183. PubMed ID: 31580642
[TBL] [Abstract][Full Text] [Related]
15. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
16. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
18. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
19. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
[TBL] [Abstract][Full Text] [Related]
20. Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.
Hwang AA; Lu J; Tamanoi F; Zink JI
Small; 2015 Jan; 11(3):319-328. PubMed ID: 25196485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
